Volume 61, Issue 4, Pages (April 2002)

Slides:

Advertisements

Similar presentations

Renal neuronal nitric oxide synthase protein expression as a marker of renal injury Attila J. Szabo, Laszlo Wagner, Aaron Erdely, Kim Lau, Chris Baylis.

Advertisements

Renal involvement in hepatitis C infection: Cryoglobulinemic glomerulonephritis Giuseppe D’Amico Kidney International Volume 54, Issue 2, Pages

Renal Stress Testing in the Assessment of Kidney Disease Lakhmir S. Chawla, Claudio Ronco Kidney International Reports Volume 1, Issue 1, Pages (May.

Evaluation and treatment of coronary artery disease in patients with end-stage renal disease Peter A. McCullough Kidney International Volume 67, Pages.

Volume 63, Issue 4, Pages (April 2003)

Plasma sodium and hypertension

Volume 68, Issue 2, Pages (August 2005)

Continuous renal replacement therapy in the critically ill patient

Progression of renal failure and hypertensive nephrosclerosis

John P. Middleton, Patrick H. Pun Kidney International

Section 5: Dialysis Interventions for Treatment of AKI

Volume 77, Issue 1, Pages 6-8 (January 2010)

Burden of chronic kidney disease: North Africa

Smoking and cardiovascular outcomes in dialysis patients: The United States Renal Data System Wave 2 Study1,2 Robert N. Foley, Charles A. Herzog, Allan.

Volume 71, Issue 8, Pages (April 2007)

Is there a pharmacologic basis for combination renin axis blockade?

Nosratola D. Vaziri, Kaihui Liang, Yaoxian Ding Kidney International

George A. Kaysen, Burl R. Don

Volume 74, Issue 6, Pages (September 2008)

Comorbidity and confounding in end-stage renal disease

Lipid redistribution in renal dysfunction

Volume 63, Issue 2, Pages (February 2003)

Volume 70, Issue 11, Pages (December 2006)

The epidemiology of chronic kidney disease

Erythropoietin and progression of CKD

Arginase in glomerulonephritis

Volume 71, Issue 6, Pages (March 2007)

Prospective randomized study of individual and group psychotherapy versus controls in recipients of renal transplants1 Lyndsay S. Baines, John T. Joseph,

Volume 70, Issue 12, Pages (December 2006)

Volume 59, Issue 4, Pages (April 2001)

Volume 62, Issue 4, Pages (October 2002)

Volume 70, Issue 7, Pages (October 2006)

Fructose intake as a risk factor for kidney stone disease

Hemodialysis arteriovenous access: Detection of stenosis and response to treatment by vascular access blood flow Steve J. Schwab, Matthew J. Oliver,

Volume 76, Issue 6, Pages (September 2009)

Volume 87, Issue 1, Pages (January 2015)

The third World Kidney Day: Looking back and thinking forward

Volume 69, Issue 12, Pages (June 2006)

Volume 69, Issue 3, Pages (February 2006)

Presentation of the 2003 Jean Hamburger Award to Robert W. Schrier

Volume 87, Issue 1, Pages (January 2015)

The kidney, a cardiovascular risk marker, and a new target for therapy

Counteracting progression of renal disease: A look into the future

Nephrology Crossword: Glomerulonephritis

In This Issue Molecular Therapy Volume 16, Issue 4, (April 2008)

Neuronal nitric oxide synthase inhibition sensitizes the tubuloglomerular feedback mechanism after volume expansion Russell Brown, Anna Ollerstam, A.

A practical approach to the treatment of depression in patients with chronic kidney disease and end-stage renal disease S. Susan Hedayati, Venkata Yalamanchili,

Shannon D. Smith, Marcia A. Wheeler, Marc I. Lorber, Robert M. Weiss

Volume 81, Issue 8, Pages (April 2012)

Volume 59, Issue 4, Pages (April 2001)

Volume 59, Issue 4, Pages (April 2001)

A man with a hole in his penis

Volume 87, Issue 5, Pages (May 2015)

Volume 73, Issue 9, Pages (May 2008)

The treatment of acute interstitial nephritis: More data at last

Organ transplantation goes to the movies

Volume 83, Issue 4, Pages (April 2013)

Volume 64, Issue 4, Pages (October 2003)

Is complement a target for therapy in renal disease?

Volume 70, Issue 6, Pages (September 2006)

Volume 62, Issue 5, (November 2002)

Volume 68, Issue 5, Pages (November 2005)

Aldosterone and potassium secretion by the cortical collecting duct

Volume 69, Issue 8, Pages (April 2006)

Volume 57, Issue 2, Pages (October 2000)

Volume 61, Issue 4, Pages (April 2002)

Volume 60, Issue 6, Pages (December 2001)

Proteinuria and hypertension with tyrosine kinase inhibitors

Sugar-sweetened beverages and chronic disease

Epidemiologic data of renal diseases from a single unit in China: Analysis based on 13,519 renal biopsies Lei-Shi Li, Zhi-Hong Liu Kidney International

Presentation transcript:

Volume 61, Issue 4, Pages 1462-1468 (April 2002) Effects of enalapril and eprosartan on the renal vascular nitric oxide system in human essential hypertension1 Christian Delles, Johannes Jacobi, Stefan John, Ingrid Fleischmann, Roland E. Schmieder Kidney International Volume 61, Issue 4, Pages 1462-1468 (April 2002) DOI: 10.1046/j.1523-1755.2002.00260.x Copyright © 2002 International Society of Nephrology Terms and Conditions

Figure 1 Contribution of the renal vascular nitric oxide system to the effects of treatment on renal plasma flow. The response of renal plasma flow (RPF) on inhibition of nitric oxide with NG-monomethyl-L-arginine (L-NMMA; that is, the change in RPF) in the respective study phases is shown on the x-axis. Changes of basal RPF with enalapril, eprosartan, and combination therapy are shown on the y-axis of panels A (r = -0.44, P = NS), B (r = -0.86, P !0.001), and C (r = -0.70, P = 0.002), respectively. Kidney International 2002 61, 1462-1468DOI: (10.1046/j.1523-1755.2002.00260.x) Copyright © 2002 International Society of Nephrology Terms and Conditions